222 related articles for article (PubMed ID: 35482822)
1. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
Luo H; Peng J; Yuan Y
Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
[TBL] [Abstract][Full Text] [Related]
2. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
3. Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
Cai Y; Dong Z; Wang J
World J Surg Oncol; 2022 Oct; 20(1):329. PubMed ID: 36192755
[TBL] [Abstract][Full Text] [Related]
4. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
Yang L; Wang L; Wu J; Wang Y
Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Wang J; Yang K; Cao J; Li L
Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
[TBL] [Abstract][Full Text] [Related]
7. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
[TBL] [Abstract][Full Text] [Related]
8. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner.
Wang T; Zhang C; Wang S
J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332
[TBL] [Abstract][Full Text] [Related]
10. hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5.
Lv H; Shi Z; Sui A; Zhang Y; Peng L; Wang M; Zhang F
J Immunol Res; 2022; 2022():4996980. PubMed ID: 35874898
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137.
Xue M; Hong W; Jiang J; Zhao F; Gao X
RNA Biol; 2020 Dec; 17(12):1811-1822. PubMed ID: 32658600
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
13. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p.
Zhang J; Mao J
Histol Histopathol; 2023 Jun; 38(6):709-724. PubMed ID: 36416408
[TBL] [Abstract][Full Text] [Related]
14. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
Tan Z; Cao F; Jia B; Xia L
Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
[TBL] [Abstract][Full Text] [Related]
15. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
Yang C; Shi J; Wang J; Hao D; An J; Jiang J
Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
[TBL] [Abstract][Full Text] [Related]
16. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
Sheng J; Liu L; Dong T; Wu X
J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803
[TBL] [Abstract][Full Text] [Related]
17. Lidocaine represses the malignant behavior of lung carcinoma cells via the circ_PDZD8/miR-516b-5p/GOLT1A axis.
Zi H; Chen L; Ruan Q
Histol Histopathol; 2022 May; 37(5):461-474. PubMed ID: 35060113
[TBL] [Abstract][Full Text] [Related]
18. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2.
Jia L; Liu M; An L; Wang H; Wang X
Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
[TBL] [Abstract][Full Text] [Related]
19. Circ_0079530 stimulates THBS2 to promote the malignant progression of non-small cell lung cancer by sponging miR-584-5p.
Fang K; Deng Y; Yang P; Zhang Y; Luo D; Wang F; Cai Z; Liu Y
Histol Histopathol; 2023 Jun; 38(6):681-693. PubMed ID: 36382967
[TBL] [Abstract][Full Text] [Related]
20. circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.
Ma H; Qu S; Zhai Y; Yang X
Cell Mol Biol Lett; 2022 Oct; 27(1):94. PubMed ID: 36273140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
